358 related articles for article (PubMed ID: 31556110)
21. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
Xue J; Jia E; Ren N; Xin H
Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850
[TBL] [Abstract][Full Text] [Related]
22. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.
Nagy Á; Lánczky A; Menyhárt O; Győrffy B
Sci Rep; 2018 Jun; 8(1):9227. PubMed ID: 29907753
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
24. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.
Chen L; Jiang M; Yuan W; Tang H
J Invest Surg; 2012 Jun; 25(3):156-61. PubMed ID: 22583011
[TBL] [Abstract][Full Text] [Related]
25. Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.
Wang Z; Ding Q; Li Y; Liu Q; Wu W; Wu L; Yu H
Tumour Biol; 2016 Nov; 37(11):14779-14787. PubMed ID: 27633066
[TBL] [Abstract][Full Text] [Related]
26. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL
Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713
[TBL] [Abstract][Full Text] [Related]
27. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
Yu LX; Zhang BL; Yang Y; Wang MC; Lei GL; Gao Y; Liu H; Xiao CH; Xu JJ; Qin H; Xu XY; Chen ZS; Zhang DD; Li FG; Zhang SG; Liu R
Oncol Rep; 2019 Jan; 41(1):257-269. PubMed ID: 30542726
[TBL] [Abstract][Full Text] [Related]
28. [Bioinformatics on vascular invasion markers in hepatocellular carcinoma via Big-Data analysis].
Chen Q; Qiu XQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):522-527. PubMed ID: 28468075
[No Abstract] [Full Text] [Related]
29. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.
Liang L; Zeng JH; Wang JY; He RQ; Ma J; Chen G; Cai XY; Hu XH
Pathol Res Pract; 2017 Dec; 213(12):1494-1509. PubMed ID: 29113686
[TBL] [Abstract][Full Text] [Related]
31. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
32. Identification of Four Oxidative Stress-Responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and miR-150-3p, in Hepatocellular Carcinoma.
Wan Y; Cui R; Gu J; Zhang X; Xiang X; Liu C; Qu K; Lin T
Oxid Med Cell Longev; 2017; 2017():5189138. PubMed ID: 28811864
[TBL] [Abstract][Full Text] [Related]
33. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of miR-1180-3p in hepatocellular carcinoma: a study based on bioinformatics analysis and RT-qPCR validation.
Zhou Z; Zhou X; Jiang Y; Qiu M; Liang X; Lin Q; Guo Q; Nong C; Huo R; Chen Q; Liu H; Liu Y; Zhu S; Wang M; Yu H
Sci Rep; 2020 Jul; 10(1):11573. PubMed ID: 32665670
[TBL] [Abstract][Full Text] [Related]
35. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
36. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
[TBL] [Abstract][Full Text] [Related]
37. Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA-mRNA network and signature analysis.
Wang F; Kang X; Li Y; Lu J; Liu X; Yan H
Sci Rep; 2024 Feb; 14(1):5042. PubMed ID: 38424172
[TBL] [Abstract][Full Text] [Related]
38. Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.
Liu M; Liu J; Wang L; Wu H; Zhou C; Zhu H; Xu N; Xie Y
PLoS One; 2014; 9(10):e109347. PubMed ID: 25275448
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
[TBL] [Abstract][Full Text] [Related]
40. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
